Can AI and Machine Learning in Sterile Manufacturing Improve Quality?
Discover how AI/ML in sterile pharmaceutical manufacturing enables predictive maintenance, quality control, contamination detection, and intelligent GMP operations.
Learn about manufacturing, supply chain optimisation and quality systems across pharmaceutical operations.
Discover how AI/ML in sterile pharmaceutical manufacturing enables predictive maintenance, quality control, contamination detection, and intelligent GMP operations.
Discover how modular pharmaceutical manufacturing and continuous production could improve flexibility, resilience, and efficiency across modern pharmaceutical operations.
Cell and gene therapy CMC strategies, quality systems, and manufacturing innovation are critical to advanced therapy development and determine scalability.
Discover how digital CMC regulatory submissions, cloud collaboration, and AI accelerate the modernisation of manufacturing approvals and global pharma operations.
The FDA PreCheck Pilot Program aims to strengthen U.S. domestic drug manufacturing through regulatory engagement, manufacturing readiness, and advanced production.
The FDA's proposed drug manufacturing modernisation rule could accelerate distributed manufacturing, digital quality systems, and pharma supply chain resilience.
Discover how innovations in AAV vector manufacturing are improving scalability, quality, and commercial readiness for next-generation gene therapies.
Discover how next-generation sequencing in cell line development is improving biologics manufacturing, quality control, and regulatory confidence.
Europe's 2026 heatwave is pushing pharmaceutical cold chain risk to the limit. Here is what supply chain leaders must do to protect drug integrity now.
ICH E6(R3) raises the governance bar for CRO and vendor oversight in clinical trials. Here's what sponsors must build into outsourcing relationships to protect trial quality and timelines.
Continuous pharmaceutical manufacturing cuts production time by up to 90% and is now backed by ICH Q13. Here’s what manufacturing leaders need to know about the shift to CM.
Find out how Quality-by-Design improves reliability and compliance in pharma and how you can maximise innovation through quality-based pharma development systems.